Skip to main content
. 2015 Apr 30;15:44. doi: 10.1186/s12886-015-0033-z

Figure 4.

Figure 4

3D appearance of mfERG recording and mfERG traces on the right eye at presentation (A,B) and one month after the intravitreal aflibercept (C,D).